316 related articles for article (PubMed ID: 28456896)
1. The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.
Kano K; Aoyama T; Maezawa Y; Nakajima T; Ikeda K; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
Int J Clin Oncol; 2017 Oct; 22(5):887-896. PubMed ID: 28456896
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
[TBL] [Abstract][Full Text] [Related]
3. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy.
Aoyama T; Yoshikawa T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A
Ann Surg Oncol; 2012 May; 19(5):1568-74. PubMed ID: 22143578
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy with S-1 followed by docetaxel for gastric cancer and CY1P0 peritoneal metastasis after relatively curative surgery.
Kanazawa Y; Kato S; Fujita I; Onodera H; Uchida E
J Nippon Med Sch; 2013; 80(5):378-83. PubMed ID: 24189356
[TBL] [Abstract][Full Text] [Related]
6. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract][Full Text] [Related]
7. [Treatment strategy for patients with CY1 gastric cancer using subgroup analyses].
Nagata H; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Sakakura C; Otsuji E
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2235-8. PubMed ID: 25731481
[TBL] [Abstract][Full Text] [Related]
8. [S-1 monotherapy achieved twenty-month survival for peritoneal lavage cytology-positive gastric cancer patient undergoing noncurative resection].
Shimoyama S; Kiyokawa T; Nishida M; Seto Y
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1411-4. PubMed ID: 22996780
[TBL] [Abstract][Full Text] [Related]
9. Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer.
Aoyama T; Sato T; Maezawa Y; Kano K; Hayashi T; Yamada T; Yukawa N; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
Int J Clin Oncol; 2017 Jun; 22(3):476-483. PubMed ID: 28176023
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study.
Kodera Y; Ito S; Mochizuki Y; Ohashi N; Tanaka C; Kobayashi D; Kojima H; Matsui T; Kondo K; Fujiwara M
Gastric Cancer; 2012 Jul; 15(3):335-7. PubMed ID: 22527184
[TBL] [Abstract][Full Text] [Related]
11. [Long-Term Disease-Free Survival through Postoperative Chemotherapy in a Case of Gastric Cancer with Peritoneal Dissemination].
Nakade H; Matsumoto S; Wakatsuki K; Tanaka T; Migita K; Ito M; Kunishige T; Kitano M; Nakatani M; Nakajima Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2055-7. PubMed ID: 26805262
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
[TBL] [Abstract][Full Text] [Related]
13. [Peritoneal lavage cytology under local anesthesia for detection of peritoneal recurrence after surgery].
Okada K; Fujiwara Y; Takahashi T; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2363-5. PubMed ID: 22202383
[TBL] [Abstract][Full Text] [Related]
14. Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis.
Nakayama I; Chin K; Matsushima T; Takahari D; Ogura M; Shinozaki E; Suenaga M; Ozaka M; Wakatsuki T; Ichimura T; Hiroki O; Yamaguchi K
Int J Clin Oncol; 2017 Dec; 22(6):1060-1068. PubMed ID: 28748355
[TBL] [Abstract][Full Text] [Related]
15. A patient with gastric adenosquamous carcinoma with intraperitoneal free cancer cells who remained recurrence-free with postoperative S-1 chemotherapy.
Ebi M; Shimura T; Yamada S; Hirata Y; Tsukamoto H; Okamoto Y; Mizoshita T; Tanida S; Kataoka H; Kamiya T; Inagaki H; Joh T
Intern Med; 2012; 51(22):3125-9. PubMed ID: 23154717
[TBL] [Abstract][Full Text] [Related]
16. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study.
Yamaguchi T; Takashima A; Nagashima K; Terashima M; Aizawa M; Ohashi M; Tanaka R; Yamada T; Kinoshita T; Matsushita H; Ishiyama K; Hosoda K; Yuasa Y; Haruta S; Kakihara N; Nishikawa K; Yunome G; Satoh T; Fukagawa T; Katai H; Boku N
Gastric Cancer; 2021 May; 24(3):701-709. PubMed ID: 33179192
[TBL] [Abstract][Full Text] [Related]
17. Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1.
Aoyama T; Yoshikawa T; Watanabe T; Hayashi T; Ogata T; Cho H; Tsuburaya A
Gastric Cancer; 2011 Aug; 14(3):274-8. PubMed ID: 21461654
[TBL] [Abstract][Full Text] [Related]
18. Survival and prognosticators of gastric cancer that recurs after adjuvant chemotherapy with S-1.
Aoyama T; Yoshikawa T; Watanabe T; Hayashi T; Ogata T; Cho H; Tsuburaya A
Gastric Cancer; 2011 Jun; 14(2):150-4. PubMed ID: 21327443
[TBL] [Abstract][Full Text] [Related]
19. [Two cases of long-term survival with CY1, stage IV gastric cancer due to surgery and postoperative chemotherapy].
Tanida T; Aoki T; Igarashi Y; Tsukao Y; Komori T; Matsumoto T; Takachi K; Nishioka K; Uemura Y; Kobayashi K
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2063-5. PubMed ID: 19106524
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study).
Kodera Y; Ito S; Mochizuki Y; Kondo K; Koshikawa K; Suzuki N; Kojima H; Kojima T; Matsui T; Takase T; Tsuboi K; Fujiwara M; Nakao A;
Eur J Surg Oncol; 2009 Nov; 35(11):1158-63. PubMed ID: 19328643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]